Catherine Skari
-
Aug- 2023 -21 August
-
21 August
-
20 August
-
20 August
-
20 August
-
10 AugustScientific News
Transfusion-Dependent Thalassaemia Patients Display Mild COVID-19, Weakened Antibody Response
In a recent research published in the journal Cureus, patients with transfusion-dependent thalassaemia (TDT) were shown to have moderate or…
Read More » -
9 AugustNews
DRUGS | EU Pulls Authorization of Adakveo for Sickle Cell Disease
The decision comes after the Committee on Medicinal Products for Human Use (CHMP) recommended in May 2023 to pull the approval following…
Read More » -
8 AugustNews
COLD AGGLUTININ DISEASE | Enjaymo Improved Life Quality in Patients for 2.5 Years
“Enjaymo provides sustained and durable treatment benefits in chronic CAD, including a continued meaningful impact on patient quality of life…
Read More » -
Jul- 2023 -31 JulyScientific Literature
Economic and Clinical Burden of Managing Transfusion-dependent β-Thalassemia in the United States
Aims: To describe clinical complications, treatment use, healthcare resource utilization (HCRU), and costs among patients with transfusion-dependent β-thalassemia (TDT) in the…
Read More » -
31 JulyScientific Literature
Efficacy and Safety of Early-start Deferiprone in Infants and Young Children with Transfusion-dependent Beta Thalassemia: Evidence for Iron Shuttling to Transferrin in a Randomized, Double-blind, Placebo-controlled, Clinical Trial (START)
Children with transfusion‐dependent thalassemia (TDT) require regular blood transfusions that, without iron‐chelation therapy, lead to iron‐overload toxicities. Current practice delays…
Read More »